These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae. Ji XW, Xue F, Kang ZS, Zhong W, Kuan IH, Yang XP, Zhu X, Li Y, Lv Y. Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31844001 [Abstract] [Full Text] [Related]
5. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen. Cazaubon Y, Venisse N, Mimoz O, Maire P, Ducher M, Bourguignon L, Goutelle S. J Antimicrob Chemother; 2017 Oct 01; 72(10):2804-2812. PubMed ID: 29091222 [Abstract] [Full Text] [Related]
6. Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia. Bader JC, Lakota EA, Dale GE, Sader HS, Rex JH, Ambrose PG, Bhavnani SM. Antimicrob Agents Chemother; 2019 Jun 01; 63(6):. PubMed ID: 30962339 [Abstract] [Full Text] [Related]
7. Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection. Goutelle S, Conrad A, Pouderoux C, Braun E, Laurent F, Gagnieu MC, Cohen S, Guitton J, Valour F, Ferry T. Front Med (Lausanne); 2021 Jun 01; 8():583086. PubMed ID: 33869238 [Abstract] [Full Text] [Related]
8. Subcutaneously administered antibiotics. Colin E, Baldolli A, Verdon R, Saint-Lorant G. Med Mal Infect; 2020 May 01; 50(3):231-242. PubMed ID: 31300245 [Abstract] [Full Text] [Related]
9. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury. Cota JM, FakhriRavari A, Rowan MP, Chung KK, Murray CK, Akers KS. Clin Ther; 2016 Sep 01; 38(9):2016-31. PubMed ID: 27586127 [Abstract] [Full Text] [Related]
10. Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data. Yoshizawa K, Ikawa K, Ikeda K, Kumon H, Ohge H, Morikawa N. Int J Antimicrob Agents; 2012 Nov 01; 40(5):427-33. PubMed ID: 22877766 [Abstract] [Full Text] [Related]
11. Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers. Wiskirchen DE, Housman ST, Quintiliani R, Nicolau DP, Kuti JL. Pharmacotherapy; 2013 Mar 01; 33(3):266-74. PubMed ID: 23400916 [Abstract] [Full Text] [Related]
12. Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? Udy AA, Lipman J, Jarrett P, Klein K, Wallis SC, Patel K, Kirkpatrick CM, Kruger PS, Paterson DL, Roberts MS, Roberts JA. Crit Care; 2015 Jan 30; 19(1):28. PubMed ID: 25632974 [Abstract] [Full Text] [Related]
13. Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery. Wittau M, Paschke S, Kurlbaum M, Scheele J, Ly NS, Hemper E, Kornmann M, Henne-Bruns D, Bulitta JB. Antimicrob Agents Chemother; 2017 Jan 30; 61(1):. PubMed ID: 27795367 [Abstract] [Full Text] [Related]
14. Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulations. Miranda Bastos AC, Vandecasteele SJ, Spinewine A, Tulkens PM, Van Bambeke F. J Antimicrob Chemother; 2018 Jun 01; 73(6):1630-1638. PubMed ID: 29579214 [Abstract] [Full Text] [Related]
15. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass. Alqahtani SA, Alsultan AS, Alqattan HM, Eldemerdash A, Albacker TB. Antimicrob Agents Chemother; 2018 Apr 01; 62(4):. PubMed ID: 29358296 [Abstract] [Full Text] [Related]
16. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections. Sauermann R, Burian B, Burian A, Jäger W, Höferl M, Stella A, Theurer S, Riedl M, Zeitlinger M. J Antimicrob Chemother; 2013 Apr 01; 68(4):895-9. PubMed ID: 23212112 [Abstract] [Full Text] [Related]
17. Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion. Riccobene TA, Carrothers TJ, Knebel W, Raber S, Chan PLS. Clin Pharmacol Drug Dev; 2021 Apr 01; 10(4):420-427. PubMed ID: 33465279 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections. Zhou J, Sulaiman Z, Llorin RM, Hee KH, Lee LS, Lye DC, Fisher DA, Tam VH. J Antimicrob Chemother; 2014 Sep 01; 69(9):2517-21. PubMed ID: 24797063 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients. Hsaiky LM, Salinitri FD, Wong J, Jennings ST, Desai NH, Lobkovich AM, Cha R. Nephrol Dial Transplant; 2019 Oct 01; 34(10):1766-1772. PubMed ID: 29992286 [Abstract] [Full Text] [Related]
20. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis. Cardone KE, Chen WZ, Grabe DW, Batzold A, Manley HJ, Lodise TP. J Antimicrob Chemother; 2014 Jul 01; 69(7):1873-6. PubMed ID: 24722842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]